search
cancer research
Trends
- 113-Year-Old Cured of DIPG, the Deadliest Childhood Brain Cancer●A 13-Year-Old Has Been Cured of DIPG, the Deadliest Childhood Brain Cancer
A 13-year-old has reportedly been cured of DIPG, a deadly childhood brain cancer that until now has had a near-zero survival rate. The news is being described as a world first and is drawing wide attention from parents, doctors and researchers, who see it as a possible turning point in treating a disease long considered untreatable, while others await peer-reviewed confirmation of the results.
- 2
Charles Kelley, member of country trio Lady A, has announced he has been diagnosed with a rare blood cancer at age 45, saying he intends to keep working through treatment. The news comes alongside a string of other cancer headlines, including Will Reeve reflecting on his late parents after revealing his own diagnosis, research on infections linked to millions of annual cancer cases, and trial results showing radiosurgery improves survival in lung cancer that has spread to the brain.
- 3Infections caused 2.3 million cancer cases in 2024, IARC study finds●A new study from the International Agency for Research on Cancer (IARC) shows that an estimated 2.3 million new cancer c
A new study from the International Agency for Research on Cancer estimates that 2.3 million new cancer cases worldwide in 2024, about 12% of all new cases, were caused by infections. Researchers say many of these cases could have been prevented through vaccination or treatment, highlighting prevention opportunities against infection-related cancers.
- 4p53 found to prevent chromothripsis by balancing transcription and replication▼p53 keeps a transcription–replication balance that prevents chromothripsis
New research reported in Nature shows that the p53 protein, best known as a tumour suppressor, maintains a balance between transcription and DNA replication in cells. When this balance is disrupted, chromosomes can shatter in a catastrophic event known as chromothripsis, a recognised driver of cancer. The findings clarify how p53 guards genome integrity beyond its established roles in halting damaged cells.
- 5
The American Association for Cancer Research is highlighting how genomic research is uncovering new layers of the biology of leukemia in children. The findings point to a deeper genetic understanding of pediatric leukemia, which could inform how the disease is studied and potentially treated. Details beyond the headline are limited, and specific study results have not been reported.
- 6Study Reports Vitamin C and DMSO Skin Cancer Results●A new study reports promising results using vitamin C + DMSO for skin # cancer , including 56% elimination in 12 weeks a
A new study reports that a combination of vitamin C and DMSO, a solvent used to carry drugs through the skin, eliminated skin cancer lesions in 56% of cases within 12 weeks, with 94% of patients avoiding surgery. Related research suggests DMSO can enhance delivery of anticancer drugs directly into tumors. The findings are drawing attention and skepticism, since skin cancer is normally treated surgically and such results would be significant if confirmed by larger trials.
- 7Study Finds Proliferative Pause Could Help Prevent Brain Metastasis●Proliferative Pause Reveals Window to Prevent Brain Metastasis
Researchers report that a 'proliferative pause' — a dormant phase cancer cells enter before spreading — may offer a critical window to intervene and stop brain metastasis before it takes hold. The findings, covered by Inside Precision Medicine, suggest targeting cells during this quiet period could prevent secondary brain tumours, a major cause of death in patients with advanced cancers such as breast cancer and melanoma.
- 8Fitness community joins breast cancer awareness push●Fitness meets the fight: Breast cancer awareness
Breast Cancer Awareness Month is drawing in the fitness world, with gyms, trainers and wellness programmes tying workouts and classes to fundraising and education about the disease. The campaign angle highlights how exercise and community events are being used to raise money for research and encourage early screening among women.
- 9NIH grants $11.7 million for blood cancer inflammation research●$11.7 million from NIH supports research on inflammation in blood cancers
The National Institutes of Health has awarded $11.7 million to researchers at WashU Medicine to study the role of inflammation in blood cancers. The funding will support investigations into how inflammatory processes drive the development and progression of these diseases, work that could inform new treatment approaches. The announcement highlights continued federal investment in cancer research.
- 10CAR-T Therapy Expands From Cancer to Autoimmune Diseases▼Enhancing CAR-T Therapy: From Cancer to Autoimmune Diseases
Researchers at Yale School of Medicine are exploring how CAR-T cell therapy, originally developed to treat blood cancers, could be adapted to treat autoimmune diseases. The approach engineers a patient's immune cells to target disease-causing cells, and scientists are now studying its potential against conditions where the immune system attacks the body itself.
- 11
Researchers have introduced LISA, a light-based method for correcting errors in cell division, according to a new release. By using light to intervene in the division process, the approach could help scientists study and potentially fix problems linked to cell division mistakes, which are associated with developmental issues and diseases such as cancer.
- 12
A Dallas-based biotech startup has been awarded a $2.6 million grant to support its cancer research efforts. The funding is expected to advance the company's work on developing new treatments for the disease. Details about the startup's identity and specific research focus were not included in the initial report.
- 13New synthetic lethal drug targets microsatellite instability cancers▼A synthetic lethal drug for microsatellite instability cancers
Researchers have reported the development of a synthetic lethal drug aimed at cancers with microsatellite instability, a genetic feature found in colorectal and other tumor types. Synthetic lethality exploits mutations unique to cancer cells, sparing healthy tissue. The work was published in Nature, and scientists say such drugs could expand treatment options for patients whose tumors resist existing immunotherapies.
- 14FSU researcher targets awareness gap on alcohol and breast cancer risk●FSU researcher aims to close awareness gap on alcohol and breast cancer risk
A Florida State University researcher is working to raise public awareness that drinking alcohol increases the risk of breast cancer. The initiative focuses on closing a knowledge gap, as many women remain unaware of the established link between alcohol consumption and cancer risk, limiting their ability to make informed health decisions.
- 15Cancer vaccine puts terminal patient into remission▼Exclusive | She was ready to die. Now she’s in remission — cancer vaccines could be the next big thing in medicine
A woman who had been prepared to die has entered remission after receiving an experimental cancer vaccine, in a report highlighting the technology as a possible next major advance in medicine. The case is being presented as evidence that therapeutic vaccines, which train the immune system to attack tumors, could transform cancer treatment.
- 16
News coverage is highlighting lung cancer cases in people who have never smoked, a group historically overlooked in screening and public awareness. Reports note that never-smokers can develop the disease, often at later diagnosis, and discussion is focusing on possible causes such as air pollution, genetic factors, and radon exposure, as well as what this means for screening guidelines and research funding.
- 17Cancer vaccines emerge as promising new frontier in medicine●She was ready to die. Now she’s in remission — cancer vaccines could be the next big thing in medicine
A terminal cancer patient who had accepted she was dying is now in remission after receiving an experimental cancer vaccine. Doctors say the case highlights the growing potential of personalized cancer vaccines, which train the immune system to attack tumors. The story is fueling optimism that such vaccines could become a major new tool in cancer treatment.